Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content

Biochemistry

Volumn 43, Issue 50, 2004, Pages 15863-15872

  Benítez, Sonia ^a   Villegas, Virtudes ^b   Bancells, Cristina ^a   Jorba, Oscar ^a   González Sastre, Francesc ^a,b   Ordóñez Llanos, Jordi ^a,b   Sánchez Quesada, José Luis ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE; HYDROLYSIS; PHOSPHOLIPIDS; PROTEINS;

BINDING AFFINITY; FAMILIAL HYPERCHOLESTEROLEMIC (FH); NONESTERIFIED FATTY ACIDS (NEFA);

BINDING ENERGY;

APOLIPOPROTEIN B; FATTY ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; PHOSPHOLIPASE A2;

ADULT; ARTICLE; BINDING AFFINITY; CIRCULAR DICHROISM; CONTROLLED STUDY; DISSOCIATION CONSTANT; FAMILIAL HYPERCHOLESTEROLEMIA; FIBROBLAST; HUMAN; HUMAN CELL; HYDROLYSIS; LIPOLYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

ANTIOXIDANTS; APOLIPOPROTEINS B; CELLS, CULTURED; CHOLESTEROL ESTERS; FATTY ACIDS, NONESTERIFIED; FIBROBLASTS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MALONDIALDEHYDE; PHOSPHOLIPASES A; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, LDL;

EID: 10844238941     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi048825z     Document Type: Article

References (54)

1. Navab, M., Berliner, J. A., Watson, A. D., Hama, S. Y., Territo, M. C., Lusis, A. J., Shih, D. M., van Lenten, B. J., Frank, J. S., Demer, L. L., Edwards, P. A., and Fogelman, A. M. (1996) The Yin and Yang of oxidation in the development of the fatty streak, Arterioscler. Thromb. Vasc. Biol. 16, 831-842.
2. Kovanen, P. T., and Pentikäinen, M. O. (2003) Circulating lipoproteins as proinflammatory and antiinflammatory particles in atherogenesis, Curr. Opin. Lipidol. 14, 411-419.
3. Holvoet, P., Vanhaecke, J., Janssens, J., Van de Werf, F., and Collen, D. (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease, Circulation 98, 1487-1494.
4. Avogaro, P., Bittolo-Bon, G., and Cazzolato, G. (1988) Presence of a modified low-density lipoprotein in humans, Arteriosclerosis 8, 79-87.
5. Shimano, H., Yamada, N., Ishibashi, S., Mokuno, H., Mori, N., Gotoda, T., Harada, K., Akamura, Y., Murasa, T., Yazaki, Y., and Takaku, F. (1991) Oxidation-labile subfraction of human plasma low-density lipoprotein isolated by ion-exchange chromatography, J. Lipid Res. 32, 763-773.
6. Sánchez-Quesada, J. L., Benítez, S., and Ordóñez-Llanos, J. (2004) Electronegative low-density lipoprotein, Curr. Opin. Lipidol. 15, 329-335.
7. Demuth, K., Myara, I., Chappey, B., Vedie, B., Pech-Ansellem, M. A., Haberland, M. E., and Moatti, N. (1996) A cytotoxic electronegative LDL subfraction is present in human plasma, Arterioscler. Thromb. Vasc. Biol. 16, 773-783.
8. Chang, Y. H., Abdalla, D. S. P., and Sevanian, A. (1997) Characterization of cholesterol oxidation products formed by oxidative modification of low-density lipoprotein, Free Radical Biol. Med. 23, 202-214.
9. Chen, C. H., Jiang, T., Yang, J. H., Jiang, W., Lu, J., Marathe, G. K., Pownall, H. J., Ballantyne, C. M., McIntyre, T. M., Henry, P. D., and Yang, C. Y. (2003) Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription, Circulation 107, 2102-2108.
10. de Castellarnau, C., Sánchez-Quesada, J. L., Benítez, S., Caveda, L., Rosa, R., Vila, L., and Ordóñez-Llanos, J. (2000) Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells, Arterioscler. Thromb. Vasc. Biol. 20, 2281-2287.
11. Sánchez-Quesada, J. L., Camacho, M., Antón, R., Benítez, S., Vila, L., and Ordóñez-Llanos, J. (2003) Electronegative LDL of FH subjects. Chemical characterization and induction of chemokine release from human endothelial cells, Atherosclerosis 166, 261-270.
12. Ziouzenkova, O., Asatryan, L., Sahady, D., Orasanu, G., Perrey, S., Cutak, B., Hassell, T., Akiyama, T. E., Berger, J. P., Sevanian, A., and Plutzky, J. (2003) Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low-density lipoprotein, J. Biol. Chem. 278, 39874-39881.
13. Benítez, S., Sánchez-Quesada, J. L., Ribas, V., Jorba, O., Blanco-Vaca, F., González-Sastre, F., and Ordóñez-Llanos, J. (2003) Platelet-activating factor acetylhydrolase is mainly associated with electronegative LDL subfraction, Circulation 108, 92-96.
14. Sánchez-Quesada, J. L., Otal-Entraigas, C., Franco, M., Jorba, O., González-Sastre, F., Blanco-Vaca, F., and Ordóñez-Llanos, J. (1999) Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with familial hypercholesterolemia, Am. J. Cardiol. 84, 655-659.
15. Sánchez-Quesada, J. L., Benítez, S., Franco, M., Otal, C., Blanco-Vaca, F., and Ordóñez-Llanos, J. (2002) Density distribution of electronegative LDL (LDL(-)) in normolipemic and hyperlipemic subjects, J. Lipid Res. 43, 699-705.
16. Sánchez-Quesada, J. L., Pérez, A., Caixàs, A., Ordóñez-Llanos, J., Carreras, G., González-Sastre, F., and de Leiva, A. (1996) Electronegative low-density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control Diabetologia 39, 1469-1476.
17. Sánchez-Quesada, J. L., Pérez, A., Caixàs, A., Rigla, M., Payés, A., Benítez, S., and Ordóñez- Llanos, J. (2001) Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification, J. Clin. Endocrinol. Metab. 86, 3243-3249.
18. Ziouzenkova, O., Asatryan, L., Akmal, M., Tetta, C., Wratten, M. L., Loseto-Wich, G., Jürgens, G., Heinecke, J., and Sevanian, A. (1999) Oxidative cross-linking of apoB100 and hemoglobin results in low-density lipoproteins modification in blood, J. Biol. Chem. 274, 18916-18924.
19. Sevanian, A., Hwang, J., Hodis, H., Cazzolatto, G., Avogaro, P., and Bittolo Bon, G. (1996) Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations, Arterioscler. Thromb. Vasc. Biol. 16, 784-793.
20. Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H. N., Hwang, J., Zamburlini, A., Maiorino, M., and Ursini, F. (1997) Electronegative LDL is a lipid hydroperoxide-enriched circulating lipoprotein, J. Lipid Res. 38, 419-428.
21. Greilberger, J., Wang, X., Ledinski, G., Chen, Q., and Jurgens, G. (1999) Presence of aldehydic epitopes on a minor low-density lipoprotein fraction, Free Radical Biol. Med. 26, 1489-1494.
22. Yang, C. Y., Raya, J. L., Chen, H. H., Chen, C. H., Abe, Y., Pownall, H. J., Taylor, A. A., and Smith, C. V. (2003) Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins, Arterioscler. Thromb. Vasc. Biol. 23, 1083-1090.
23. Ursini, F., Zamburlini, A., Cazzolatto, G., Maiorino, M., Bittolo Bon, G., and Sevanian, A. (1998) Posprandial plasma lipid hydroperoxides: a possible link between diet and atherosclerosis, Free Radical Biol. Med. 25, 250-252.
24. Benítez, S., Sánchez-Quesada, J. L., Lucero, L., Arcelus, R., Ribas, V., Jorba, O., Castellví, A., Alonso, E., Blanco-Vaca, F., and Ordóñez-Llanos, J. (2002) Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated nonesterified fatty acids, Atherosclerosis 160, 223-232.
25. Chappey, B., Myara, I., Benoit, M. O., Maziere, C., Maziere, J. C., and Moatti, N. (1995) Characteristics of ten charge-differing subfractions isolated from human native low-density lipoprotein (LDL). No evidence of peroxidative modification, Biochim. Biophys. Acta 1259, 261-270.
26. Benítez, S., Ordóñez-Llanos, J., Franco, M., Marín, C., Paz, E., López-Miranda, J., Otal, C., Pérez-Jiménez, F., and Sánchez-Quesada, J. L. (2004) Effect of simvastatin in familial hypercholesterolemia on the affinity of charge-differing low-density lipoprotein subfractions to the low-density lipoprotein receptor, Am. J. Cardiol. 93, 414-420.
27. Foucher, C., Lagrost, L., Maupoil, V., le Meste, M., Rochette, L., and Gambert, P. (1996) Alterations of lipoprotein fluidity by non-esterified fatty acids known to affect cholesteryl ester transfer protein activity, Eur. J. Biochem. 236, 436-442.
28. Sánchez-Quesada, J. L., Ortega, H., Payés-Romero, A., Serrat-Serrat, J., González-Sastre, F., Lasunción, M. A., and Ordóñez-Llanos, J. (1997) LDL from aerobically-trained subjects shows higher resistance to oxidative modification than LDL from sedentary subjects, Atherosclerosis 132, 207-213.
29. Fukunaga, K., Suzuki, T., and Takama, K. (1993) Highly sensitive high-performance liquid chromatography for the measurement of malondialdehyde in biological samples, J. Chromatogr. 621, 77-81.
30. Habeeb, A. F. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid, Anal. Biochem. 14, 328-336.
31. Goldstein, J. L., Ho, Y. K., Basu, S. K., and Brown, M. S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, prducing massive cholesterol deposition, Proc. Natl. Acad. Sci. U.S.A. 76, 333-337.
32. Hakala, J. K., Öörni, K., Ala-Korpela, M., and Kovanen, P. T. (1999) Lipolytic modification of LDL by phospholipase A2 induces particle aggregation in the absence and fusion in the presence of heparin, Arterioscler. Thromb. Vasc. Biol. 19, 1276-1283.
33. Patton, G. M., and Robins, S. J. (1998) Separation and quantitation of phospholipid classes by HPLC, in Lipoprotein protocols (Ordovás, J. M., Ed.) pp 193-216, Humana Press, Totowa, NJ.
34. Stephan, Z. F., and Yurachek, E. C. (1993) Rapid fluorimetric assay of LDL receptor activity by DiI labelled LDL, J. Lipid Res. 34, 325-330.
35. Innerarity, T. L., Pitas, R. E., and Mahley, R. W. (1986) Lipoprotein-receptor interactions in plasma lipoproteins, Methods Enzymol. 129, 542-566.
36. Bradford, M. A. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248-254.
37. Scatchard, G. (1949) The attractions of proteins for small molecules and ions, Ann. N.Y. Acad. Sci. 51, 660-672.
38. Cheng, Y. C., and Prussoff, W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction, Biochem. Phamacol. 22, 3099-3108.
39. Pitas, R. E., Friera, A., McGuire, J., and Dejager, S. (1992) Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblasts, Arterioscler. Thromb. 12, 1235-1244.
40. -, Free Radical Biol. Med. 31, 82-89.
41. Lobley, A., and Wallace, B. A. (2001) DICHROWEB: a website for the analysis of protein secondary structure from circular dichroism spectra, Biophys. J. 80, 373a.
42. Lobley, A., Whitmore, L., and Wallace, B. A. (2002) DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra, Bioinformatics 18, 211-212.
43. Brown, M. S., and Goldstein, J. L. (1983) Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis, Annu. Rev. Biochem. 52, 223-261.
44. Steinbrecher, U. P. (1987) Oxidation of human low-density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid decomposition products, J. Biol. Chem. 262, 3603-3608.
45. Segrest, J. P., Jones, M. K., de Loof, H., and Dashti, N. (2001) Structure of apolipoprotein B-100 in low-density lipoproteins, J. Lipid Res. 42, 1346-1367.
46. Chi Chen, G., and Kane, J. P. (1975) Temperature dependence of the optical activity of human serum low-density lipoprotein. The role of lipids, Biochemistry 14, 3357-3362.
47. Lund-Katz, S., Laplaud, P. M., Philips, M. C., and Chapman, M. J. (1998) Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction, Biochemistry 37, 12867-12874.
48. Aviram, M., Lund-Katz, S., Phillips, M. C., and Chait, A. (1988) The influence of the triglyceride content of low-density lipoprotein on the interaction of apolipoprotein B-100 with cells, J. Biol. Chem. 263, 16842-16848.
49. McKeone, B. J., Patsch, J. R., and Pownall, H. J. (1993) Plasma triglycerides determine low-density lipoprotein composition, physical properties, and cell-specific binding in cultured cells, J. Clin. Invest. 91, 1926-1933.
50. Vanderyse, L., Devreese, A. M., Baert, J., Vanloo, B., Lins, L., Ruysschaert, J. M., and Rosseneu, M. (1992) Structural and functional properties of apolipoprotein B in chemically modified low-density lipoproteins, Atherosclerosis 97, 187-199.
51. Chi Chen, G., Liu, W., Duchateau, P., Allaart, J., Hamilton, R. L., Mendel, C. M., Lau, K., Hardman, D. A., Frost, P. H., Malloy, M. J., and Kane, J. P. (1994) Conformational differences in human apolipoprotein B-100 among subspecies of low-density lipoproteins (LDL), J. Biol. Chem. 269, 29121-29128.
52. McNamara, J. R., Small, D. M., Li, Z., and Schaefer, E. J. (1996) Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B, J. Lipid Res. 37, 1924-1935.
53. Nigon, F., Lesnik, P., Pouis, M., and Chapman, M. J. (1991) Discrete subspecies of human low-density lipoprotein are heterogeneous in their interaction with the cellular LDL receptor, J. Lipid Res. 32, 1741-1753.
54. Kleinman, Y., Krul, E. S., Burnes, M., Aronson, W., Pfleger, B., and Schonfeld, G. (1988) Lipolysis of LDL with phospholipase A2 alters the expression of selected apoB100 epitopes and the interaction of LDL with cells, J. Lipid Res. 29, 729-743.